At Multiple Sclerosis News Today, stories about the keto diet, myelin repair, and vitamin D topped this year's most-read list ...

Effective targeted treatment of multiple sclerosis (MS) and even the repair of damaged nerves caused by the disease could soon be within grasp, thanks to yet another breakthrough in the field of small ...

Trophos SA a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, ...

A pregnancy hormone may help repair the damage to nerves caused by multiple sclerosis, Canadian research suggests. The Journal of Neuroscience study, by the University of Calgary, may explain why MS ...

Multiple sclerosis (MS) is a debilitating inflammatory autoimmune disease that affects the central nervous system (CNS). While sufferers can experience long periods of remission where common symptoms ...

Advanced MRI techniques can differentiate between degenerative and reparative processes in MS lesions, offering insights into disease progression. Quantitative MRI (qMRI) provides detailed biophysical ...

Interim results from 4 MS and 6 PD completers demonstrate significant central nervous system (CNS) target engagement of CNM-Au8. The data indicate catalytic bioenergetic improvements across important ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Damage caused by multiple sclerosis could be reversed by activating stem cells that can repair injury in the ...

SALT LAKE CITY, Sept. 11, 2020 /PRNewswire/ -- Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company, today announced the presentation of interim results from the REPAIR-MS and ...